These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8078839)
21. Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview. Reissmann T; Felberbaum R; Diedrich K; Engel J; Comaru-Schally AM; Schally AV Hum Reprod; 1995 Aug; 10(8):1974-81. PubMed ID: 8567825 [TBL] [Abstract][Full Text] [Related]
22. Gonadotropin-releasing hormone and its clinical applications. Loucopoulos A; Ferin M Obstet Gynecol Annu; 1984; 13():275-88. PubMed ID: 6326010 [TBL] [Abstract][Full Text] [Related]
23. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH. Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511 [TBL] [Abstract][Full Text] [Related]
24. [Gonadotropin releasing hormone and analogs. Physiology and pharmacology]. Kiesel L; Runnebaum B Gynakol Geburtshilfliche Rundsch; 1992; 32(1):22-30. PubMed ID: 1325231 [TBL] [Abstract][Full Text] [Related]
30. Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue? Orvieto R; Meltcer S; Liberty G; Rabinson J; Anteby EY; Nahum R Gynecol Endocrinol; 2012 Jun; 28(6):422-4. PubMed ID: 22578028 [TBL] [Abstract][Full Text] [Related]
31. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay. Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831 [TBL] [Abstract][Full Text] [Related]
32. Extending the use of gonadotropin-releasing hormone agonists: the emerging role of steroidal and nonsteroidal agents. Lemay A; Surrey ES; Friedman AJ Fertil Steril; 1994 Jan; 61(1):21-34. PubMed ID: 8293841 [TBL] [Abstract][Full Text] [Related]
33. Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients. Hosseini MA; Aleyasin A; Saeedi H; Mahdavi A J Obstet Gynaecol Res; 2010 Jun; 36(3):605-10. PubMed ID: 20598044 [TBL] [Abstract][Full Text] [Related]
35. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. Behre HM; Nashan D; Hubert W; Nieschlag E J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833 [TBL] [Abstract][Full Text] [Related]
36. Treatment of endometriosis in monkeys: effectiveness of continuous infusion of a gonadotropin-releasing hormone agonist compared to treatment with a progestational steroid. Mann DR; Collins DC; Smith MM; Kessler MJ; Gould KG J Clin Endocrinol Metab; 1986 Dec; 63(6):1277-83. PubMed ID: 3097054 [TBL] [Abstract][Full Text] [Related]
37. Gonadotropin-releasing hormone and its analogs. Conn PM; Crowley WF Annu Rev Med; 1994; 45():391-405. PubMed ID: 8198390 [TBL] [Abstract][Full Text] [Related]
38. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study. Graña-Barcia M; Liz-Lestón J; Lado-Abeal J Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586 [TBL] [Abstract][Full Text] [Related]